R Anderson1, H C Steel, R Cockeran, A von Gottberg, L de Gouveia, K P Klugman, T J Mitchell, C Feldman. 1. Medical Research Council (MRC) Unit for Inflammation and Immunity, Department of Immunology, Faculty of Health Sciences, University of Pretoria, and Tshwane Academic Division of the National Health Laboratory Service, South Africa. ronald.anderson@up.ac.za
Abstract
OBJECTIVES: To compare the effects of subinhibitory concentrations of amoxicillin, ceftriaxone, azithromycin, clarithromycin, erythromycin, telithromycin, clindamycin, ciprofloxacin, moxifloxacin, tobramycin and doxycycline on pneumolysin production by a macrolide-susceptible strain and two macrolide-resistant strains [erm(B) or mef(A)] of Streptococcus pneumoniae. METHODS: Pneumolysin was assayed using a functional procedure based on the influx of Ca(2+) into human neutrophils. RESULTS: Only the macrolides/macrolide-like agents caused significant attenuation of the production of pneumolysin, which was evident with all three strains of the pneumococcus. CONCLUSIONS: Macrolides, at sub-MICs, but not other classes of antibiotic, subvert the production of pneumolysin, even in the presence of (and irrespective of the mechanism of) macrolide resistance in S. pneumoniae.
OBJECTIVES: To compare the effects of subinhibitory concentrations of amoxicillin, ceftriaxone, azithromycin, clarithromycin, erythromycin, telithromycin, clindamycin, ciprofloxacin, moxifloxacin, tobramycin and doxycycline on pneumolysin production by a macrolide-susceptible strain and two macrolide-resistant strains [erm(B) or mef(A)] of Streptococcus pneumoniae. METHODS: Pneumolysin was assayed using a functional procedure based on the influx of Ca(2+) into human neutrophils. RESULTS: Only the macrolides/macrolide-like agents caused significant attenuation of the production of pneumolysin, which was evident with all three strains of the pneumococcus. CONCLUSIONS:Macrolides, at sub-MICs, but not other classes of antibiotic, subvert the production of pneumolysin, even in the presence of (and irrespective of the mechanism of) macrolide resistance in S. pneumoniae.
Authors: M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij Journal: Clin Microbiol Infect Date: 2011-11 Impact factor: 8.067
Authors: Rudolf Lucas; Supriya Sridhar; Ferenc G Rick; Boris Gorshkov; Nagavedi S Umapathy; Guang Yang; Aluya Oseghale; Alexander D Verin; Trinad Chakraborty; Michael A Matthay; Evgeny A Zemskov; Richard White; Norman L Block; Andrew V Schally Journal: Proc Natl Acad Sci U S A Date: 2012-01-23 Impact factor: 11.205
Authors: István Czikora; Abdel Alli; Hui-Fang Bao; David Kaftan; Supriya Sridhar; Hans-Jürgen Apell; Boris Gorshkov; Richard White; Astrid Zimmermann; Albrecht Wendel; Meike Pauly-Evers; Jürg Hamacher; Irène Garcia-Gabay; Bernhard Fischer; Alexander Verin; Zsolt Bagi; Jean Francois Pittet; Waheed Shabbir; Rosa Lemmens-Gruber; Trinad Chakraborty; Ahmed Lazrak; Michael A Matthay; Douglas C Eaton; Rudolf Lucas Journal: Am J Respir Crit Care Med Date: 2014-09-01 Impact factor: 21.405
Authors: J G Nel; A J Theron; C Durandt; G R Tintinger; R Pool; T J Mitchell; C Feldman; R Anderson Journal: Clin Exp Immunol Date: 2016-03-02 Impact factor: 4.330
Authors: Rudolf Lucas; Guang Yang; Boris A Gorshkov; Evgeny A Zemskov; Supriya Sridhar; Nagavedi S Umapathy; Agnieszka Jezierska-Drutel; Irina B Alieva; Martin Leustik; Hamid Hossain; Bernhard Fischer; John D Catravas; Alexander D Verin; Jean-François Pittet; Ruth B Caldwell; Timothy J Mitchell; Stephen D Cederbaum; David J Fulton; Michael A Matthay; Robert W Caldwell; Maritza J Romero; Trinad Chakraborty Journal: Am J Respir Cell Mol Biol Date: 2012-05-10 Impact factor: 6.914